SERIES D (WORLD EQUITY INCOME SERIES) OCSE:NOVO B Holdings History
SERIES D (WORLD EQUITY INCOME SERIES)'s Novo Nordisk AS Holding Summary
As of 2024-09-30, Guggenheim Variable Funds Trust held 11,400.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr1.34 Mil. This investment constitutes 1.15% of their stock portfolio, and Guggenheim Variable Funds Trust now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2024Q1. And since then SERIES D (WORLD EQUITY INCOME SERIES) has made 2 purchases of OCSE:NOVO B, at an average price of kr843.16, for a total of 12,300.00 shares. In addition, there have been 1 sales at an average price of kr906.83 for 900.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, SERIES D (WORLD EQUITY INCOME SERIES)'s estimated gain on his OCSE:NOVO B holdings is kr-4.83 Mil, reflecting a -46.56% gain to date.
SERIES D (WORLD EQUITY INCOME SERIES) OCSE:NOVO B (kr414.60) Holding Chart
SERIES D (WORLD EQUITY INCOME SERIES) OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
